A small but growing body of evidence suggests that a minimally invasive surgical procedure called lymphovenous anastomosis ...

The country is facing a coming wave of dementia for its ageing population, and is investing in research into drugs, ...

Researchers from the NeuroAD group (Neuropathology of Alzheimer's Disease) within the Department of Cell Biology, Genetics ...

Science’s success at staving off death from heart disease or cancer has made another diagnosis more likely: Dementia.

A study of 470,000 people reveals that the APOE gene could be behind 90% of Alzheimer's cases in the world today.

A new study study finds that brain swelling (ARIA-E) from Alzheimer's drugs identifies the regions where amyloid plaques are being cleared most effectively.

Science’s success at staving off death from heart disease or cancer has made another diagnosis more likely: Dementia.

I understand that there is treatment for the beginning stages of Alzheimer's disease that can stave off serious decline.

Late last year, Health Canada approved lecanemab, a monoclonal antibody that clears amyloid plaques — a hallmark indicator of Alzheimer’s disease — in people with early-stage dementia while symptoms ...

Scientists have identified prematurely aged astrocytes in the brains of Alzheimer’s patients, particularly those with the APOE4 risk gene. Their findings suggest that cellular senescence in these ...

A new blood test could predict when Alzheimer’s will strike — years before symptoms begin. Scientists at Washington University School of Medicine in St. Louis have created a way to estimate when a ...